Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Technology improves odds for critically ill

17.03.2008
Large numbers of unnecessary deaths and avoidable medical complications in intensive care units (ICU) are attributable to the difficulties of treating high glucose levels in critically ill patients’ blood. That is about to change for the better thanks to a new automated insulin delivery system developed by European researchers.

A common side effect of stress and trauma in critically ill patients is a rapid increase in blood glucose levels. As with diabetes, the levels can be reduced and controlled by the infusion of insulin. But glucose levels peak and change much more quickly in the ICU environment and there is little room for trial and error. If the situation is not normalised, then complications and even deaths can and do occur.

Twice in the past, Europe-wide studies and trials were put in place to try and come up with a solution to the problem. But in both cases they were prematurely halted because researchers could not solve the problem of overcompensating and patients developing hypoglycaemia, or abnormally low blood sugar levels.

“What these studies did clearly indicate is that the establishment of normal glucose levels in critically ill patients is very difficult to achieve without some sort of automated system to help the nurses,” says Dr Martin Ellmerer, scientific coordinator of the CLINICIP project which has developed just such a system.

Nurses’ no-nonsense approach
CLINICIP started by surveying ICUs in a number of European hospitals and interviewing nursing staff. “We found out that ICU staff did not want to see additional catheters in patients, they did not want extra equipment taking up space, and costs had to be kept right down so as not to eat into funds for other vital equipment,” says Ellmerer. “So, right from the start the requirements were really tough.”

Partners in this EU-funded project, academic medical institutions plus one private-sector medical equipment manufacturer, decided they needed to develop a two-step approach. “We first developed a decision-support system which met all the criteria outlined by the ICU staff, and later developed a fully automated system,” he tells ICT Results.

At the heart of both systems is a sophisticated bit of computer software (an algorithm) written especially for this project.

With the decision-support system, nurses still have to draw blood from patients in the traditional way and test it for glucose levels. They enter the information via the user interface – a touch screen – the researchers have developed. The algorithm takes over at this stage, calculates how much insulin is needed and automatically administers it. It also alerts the nurse when a new blood sample needs to be taken and analysed – half an hour in the worst cases and up to four hours in less severe cases.

“We have fully functioning prototypes of the decision-support system which we successfully trialled in ICUs at different hospitals around Europe,” Ellmerer says. The project’s industrial partner, B. Braun Melsungen AG, is ready to go into commercial production of the system working together with the clinical partners.

“We will first have to go through an approval process and the systems should be commercially available to hospitals in mid-2009,” Ellmerer says. B. Braun is one of the leading manufacturers of infusion systems used in hospitals, and the CLINICIP technology will be incorporated into these as it was during the trials.

Developing the real deal
At the same time the prototype was being developed and tested, CLINICIP researchers were working on sensors for a fully automated, closed-loop control system to both monitor glucose levels and administer insulin with no involvement from a nurse.

The drawback of this is that a dedicated needle is necessary. “Unfortunately, this is unavoidable for a fully automated system,” Ellmerer points out. Using fibre-optic technology the needle draws blood, sends it for analysis and then returns it to the patient’s vein as well as administering the necessary dose of insulin.

“We have performed a proof-of-concept study to show we are able to establish glucose control in a clinical setting,” Ellmerer says.

To develop the sensor technology further and then commercialise it, a spin-off company will be set up with Ellmerer as CEO and one of the shareholders. The other shareholders are individuals from project partners in CLINICIP. The spin-off will work closely with B. Braun and the partners, although they are not stakeholders in it.

Ellmerer expects the fully automated two-step system to be commercially available in 2011.

“Our research and the products which result from it should have a pretty fundamental impact on ICUs,” he says. “They should improve survival chances, reduce complications, such as sepsis and organ failure, and reduce the time patients need to spend in ICUs.”

Ahmed ElAmin | alfa
Further information:
http://cordis.europa.eu/ictresults/index.cfm/section/news/tpl/article/id/89612

More articles from Information Technology:

nachricht Stable magnetic bit of three atoms
21.09.2017 | Sonderforschungsbereich 668

nachricht Drones can almost see in the dark
20.09.2017 | Universität Zürich

All articles from Information Technology >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: LaserTAB: More efficient and precise contacts thanks to human-robot collaboration

At the productronica trade fair in Munich this November, the Fraunhofer Institute for Laser Technology ILT will be presenting Laser-Based Tape-Automated Bonding, LaserTAB for short. The experts from Aachen will be demonstrating how new battery cells and power electronics can be micro-welded more efficiently and precisely than ever before thanks to new optics and robot support.

Fraunhofer ILT from Aachen relies on a clever combination of robotics and a laser scanner with new optics as well as process monitoring, which it has developed...

Im Focus: The pyrenoid is a carbon-fixing liquid droplet

Plants and algae use the enzyme Rubisco to fix carbon dioxide, removing it from the atmosphere and converting it into biomass. Algae have figured out a way to increase the efficiency of carbon fixation. They gather most of their Rubisco into a ball-shaped microcompartment called the pyrenoid, which they flood with a high local concentration of carbon dioxide. A team of scientists at Princeton University, the Carnegie Institution for Science, Stanford University and the Max Plank Institute of Biochemistry have unravelled the mysteries of how the pyrenoid is assembled. These insights can help to engineer crops that remove more carbon dioxide from the atmosphere while producing more food.

A warming planet

Im Focus: Highly precise wiring in the Cerebral Cortex

Our brains house extremely complex neuronal circuits, whose detailed structures are still largely unknown. This is especially true for the so-called cerebral cortex of mammals, where among other things vision, thoughts or spatial orientation are being computed. Here the rules by which nerve cells are connected to each other are only partly understood. A team of scientists around Moritz Helmstaedter at the Frankfiurt Max Planck Institute for Brain Research and Helene Schmidt (Humboldt University in Berlin) have now discovered a surprisingly precise nerve cell connectivity pattern in the part of the cerebral cortex that is responsible for orienting the individual animal or human in space.

The researchers report online in Nature (Schmidt et al., 2017. Axonal synapse sorting in medial entorhinal cortex, DOI: 10.1038/nature24005) that synapses in...

Im Focus: Tiny lasers from a gallery of whispers

New technique promises tunable laser devices

Whispering gallery mode (WGM) resonators are used to make tiny micro-lasers, sensors, switches, routers and other devices. These tiny structures rely on a...

Im Focus: Ultrafast snapshots of relaxing electrons in solids

Using ultrafast flashes of laser and x-ray radiation, scientists at the Max Planck Institute of Quantum Optics (Garching, Germany) took snapshots of the briefest electron motion inside a solid material to date. The electron motion lasted only 750 billionths of the billionth of a second before it fainted, setting a new record of human capability to capture ultrafast processes inside solids!

When x-rays shine onto solid materials or large molecules, an electron is pushed away from its original place near the nucleus of the atom, leaving a hole...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

Event News

“Lasers in Composites Symposium” in Aachen – from Science to Application

19.09.2017 | Event News

I-ESA 2018 – Call for Papers

12.09.2017 | Event News

EMBO at Basel Life, a new conference on current and emerging life science research

06.09.2017 | Event News

 
Latest News

Fraunhofer ISE Pushes World Record for Multicrystalline Silicon Solar Cells to 22.3 Percent

25.09.2017 | Power and Electrical Engineering

Usher syndrome: Gene therapy restores hearing and balance

25.09.2017 | Health and Medicine

An international team of physicists a coherent amplification effect in laser excited dielectrics

25.09.2017 | Physics and Astronomy

VideoLinks
B2B-VideoLinks
More VideoLinks >>>